{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:19:00Z","timestamp":1792606740411,"version":"4.5.0"},"reference-count":31,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background<\/jats:title>\n<jats:p>Although topical amphotericin B cream is effective for the treatment of nondermatophyte mold onychomycosis <jats:italic>in vitro<\/jats:italic>, studies of its effectiveness and safety <jats:italic>in vivo<\/jats:italic> are limited.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>We studied the effectiveness and safety of topical 0.3% amphotericin B in 30% dimethyl sulfoxide cream (amphotericin B cream) in nondermatophyte mold onychomycosis using the vehicle cream 30% dimethyl sulfoxide cream as control.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This randomized controlled study was conducted between January 2019 and November 2020. Patients diagnosed with nondermatophyte mold onychomycosis were randomly divided into two groups of ten patients each: one treated with amphotericin B cream and the other with the vehicle cream. Clinical and mycological cure as well as safety were evaluated.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st4\">\n<jats:title>Results<\/jats:title>\n<jats:p>Ten patients each treated with amphotericin B cream and the vehicle cream were included in the study, but only nine patients in the vehicle cream group were available for follow up. All the 19 evaluable patients had distal lateral subungual onychomycosis and the great toenails were affected in 18 (94.7%) of these. Mycological cure was achieved in 8 (80%) patients treated with amphotericin B cream and in 4 (44.4%) patients using the control (vehicle) cream. Clinical cure was achieved in 7 (70%) patients treated with amphotericin B cream, but only in 2 (22.2%) patients on the control cream. No adverse events were observed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st5\">\n<jats:title>Limitations<\/jats:title>\n<jats:p>The small sample size and the fact that PCR fungal identification that provides accurate identification of fungal species was not performed are limitations of our study.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st6\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Topical amphotericin B cream was both very effective and safe in the treatment nondermatophyte mold onychomycosis. The control (vehicle) cream containing 30% dimethyl sulfoxide also demonstrated some antifungal activity.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijdvl_359_2021","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T06:34:57Z","timestamp":1635230097000},"page":"494-499","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness and safety of topical amphotericin B in 30% dimethyl sulfoxide cream versus 30% dimethyl sulfoxide cream for nondermatophyte onychomycosis treatment: A pilot study"],"prefix":"10.25259","volume":"88","author":[{"given":"Charussri","family":"Leeyaphan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bordeesuda","family":"Suiwongsa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy General Pharmaceutical Production Division, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phojana","family":"Komesmuneeborirak","sequence":"additional","affiliation":[{"name":"Department of Pharmacy General Pharmaceutical Production Division, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungsima","family":"Kiratiwongwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supisara","family":"Wongdama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waranyoo","family":"Prasong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salisa","family":"Supcharoenkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanas","family":"Bunyaratavej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"10.25259\/IJDVL_359_2021\/ref-1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","article-title":"Therapies for the treatment of onychomycosis","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/bjd.18860","article-title":"Eclipsed phenomenon: The relationship between nail and foot infections in patients presenting with nondermatophyte infections after dermatophyte infections in onychomycosis","volume":"183","author":"Bunyaratavej","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/1346-8138.12768","article-title":"Distinct characteristics of Scytalidium dimidiatum and non-dermatophyte onychomycosis as compared with dermatophyte onychomycosis","volume":"42","author":"Bunyaratavej","year":"2015","journal-title":"J Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2230.2004.01446.x","article-title":"Prevalence of foot diseases in outpatients attending the institute of Dermatology, Bangkok, Thailand","volume":"29","author":"Ungpakorn","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11046-016-0085-5","article-title":"In vitro antifungal susceptibility of Neoscytalidium dimidiatum clinical isolates from Malaysia","volume":"182","author":"James","year":"2017","journal-title":"Mycopathologia"},{"key":"10.25259\/IJDVL_359_2021\/ref-6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2011.02.038","article-title":"Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment","volume":"66","author":"Gupta","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-7","first-page":"528","article-title":"Survey and comparison of clinical and laboratory findings among subjects with fingernail and toenail onychomycosis","volume":"51","author":"Leeyaphan","year":"2020","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.25259\/IJDVL_359_2021\/ref-8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1365-2133.1999.02739.x","article-title":"Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer","volume":"140","author":"Downs","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0190-9622(00)90129-4","article-title":"Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases","volume":"42","author":"Tosti","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mycmed.2013.01.002","article-title":"Scytalidium and scytalidiosis: What's new in 2012?","volume":"23","author":"Machouart","year":"2013","journal-title":"J Mycol Med"},{"key":"10.25259\/IJDVL_359_2021\/ref-11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clindermatol.2009.12.006","article-title":"Onychomycosis","volume":"28","author":"Welsh","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: Spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.25259\/IJDVL_359_2021\/ref-13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijantimicag.2009.05.006","article-title":"Genotyping and in vitro antifungal susceptibility of Neoscytalidium dimidiatum isolates from different origins","volume":"34","author":"Madrid","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.25259\/IJDVL_359_2021\/ref-14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/jac\/dkn011","article-title":"In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates","volume":"61","author":"Lacroix","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.25259\/IJDVL_359_2021\/ref-15","first-page":"142","author":"Guarro","year":"2000"},{"key":"10.25259\/IJDVL_359_2021\/ref-16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1381612822666161027103640","article-title":"Exploring the role of nanoparticles in amphotericin B delivery","volume":"23","author":"Zaioncz","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.25259\/IJDVL_359_2021\/ref-17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000335093","article-title":"Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B","volume":"223","author":"Lurati","year":"2011","journal-title":"Dermatology"},{"key":"10.25259\/IJDVL_359_2021\/ref-18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.colsurfb.2014.01.014","article-title":"Amphotericin B topical microemulsion: Formulation, characterization and evaluation","volume":"116","author":"Butani","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.25259\/IJDVL_359_2021\/ref-19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/10717544.2014.933284","article-title":"Nanoemulsion gel-based topical delivery of an antifungal drug: In vitro activity and in vivo evaluation","volume":"23","author":"Hussain","year":"2016","journal-title":"Drug Deliv"},{"key":"10.25259\/IJDVL_359_2021\/ref-20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/11263504.2020.1779846","article-title":"Antifungal activity of dimethyl sulfoxide against Botrytis cinerea and phytotoxicity on tomato and lettuce plants","volume":"154","author":"Petruccelli","year":"2020","journal-title":"Plant Biosyst"},{"key":"10.25259\/IJDVL_359_2021\/ref-21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3314\/jjmm.49.125","article-title":"Dimethyl sulfoxide (DMSO) inhibits the germination of Candida albicans and the arthrospores of Trichophyton mentagrophytes","volume":"49","author":"Randhawa","year":"2008","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"key":"10.25259\/IJDVL_359_2021\/ref-22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.22159\/ajpcr.2020.v13i12.39645","article-title":"Amphotericin B topical extemporaneous preparations for the treatment of nondermatophytic onychomycosis","volume":"13","author":"Komesmuneeborirak","year":"2020","journal-title":"Asian J Pharm Clin Res"},{"key":"10.25259\/IJDVL_359_2021\/ref-23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/archdermatol.2011.267","article-title":"A new classification system for grading the severity of onychomycosis: Onychomycosis severity index","volume":"147","author":"Carney","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-24","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jdv.16394","article-title":"Onychomycosis: A review","volume":"34","author":"Gupta","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.25259\/IJDVL_359_2021\/ref-25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11046-012-9580-5","article-title":"Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: A pilot study of 25 patients","volume":"175","author":"Cursi \u00cd","year":"2013","journal-title":"Mycopathologia"},{"key":"10.25259\/IJDVL_359_2021\/ref-26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/09546634.2015.1109029","article-title":"Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis","volume":"27","author":"Bunyaratavej","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.25259\/IJDVL_359_2021\/ref-27","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1111\/jocd.13291","article-title":"Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: Yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment","volume":"19","author":"Bunyaratavej","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13047-019-0332-3","article-title":"The use of urea for the treatment of onychomycosis: A systematic review","volume":"12","author":"Dars","year":"2019","journal-title":"J Foot Ankle Res"},{"key":"10.25259\/IJDVL_359_2021\/ref-29","first-page":"24","article-title":"Dimethyl sulfoxide: History, chemistry, and clinical utility in dermatology","volume":"5","author":"Capriotti","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.25259\/IJDVL_359_2021\/ref-30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3314\/jjmm.47.313","article-title":"The effect of dimethyl sulfoxide (DMSO) on the growth of dermatophytes","volume":"47","author":"Randhawa","year":"2006","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"key":"10.25259\/IJDVL_359_2021\/ref-31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/1567-1364.12091","article-title":"Dimethyl sulfoxide induces oxidative stress in the yeast Saccharomyces cerevisiae","volume":"13","author":"Sadowska-Bartosz","year":"2013","journal-title":"FEMS Yeast Res"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/effectiveness-and-safety-of-topical-amphotericin-b-in-30-dimethyl-sulfoxide-cream-versus-30-dimethyl-sulfoxide-cream-for-nondermatophyte-onychomycosis-treatment-a-pilot-study\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/effectiveness-and-safety-of-topical-amphotericin-b-in-30-dimethyl-sulfoxide-cream-versus-30-dimethyl-sulfoxide-cream-for-nondermatophyte-onychomycosis-treatment-a-pilot-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T11:53:52Z","timestamp":1679313232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/effectiveness-and-safety-of-topical-amphotericin-b-in-30-dimethyl-sulfoxide-cream-versus-30-dimethyl-sulfoxide-cream-for-nondermatophyte-onychomycosis-treatment-a-pilot-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":31,"alternative-id":["10.25259\/IJDVL_359_2021"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_359_2021","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"article-number":"494"}}